Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H-pylori eradication?

被引:5
作者
Asante, MA [1 ]
Mendall, MA [1 ]
Northfield, TC [1 ]
机构
[1] St George Hosp, Sch Med, Dept Gastroenterol Endocrinol & Metab, London SW17 0RE, England
关键词
dyspepsia; Helicobacter pylori; peptic ulcer;
D O I
10.1097/00042737-199803000-00014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective To identify which Helicobacter pylori-positive dyspeptic patients have an increased likelihood of having peptic ulcer and may thus be more likely to benefit from empirical H. pylori eradication therapy. Methods 622 out of 740 consecutive dyspeptic subjects (median age 45 years, range 14-91, 51% male) attending for rapid access endoscopy were eligible for the study. Demographic data and endoscopic findings were recorded. H. pylori status was determined by urease and histology. Results In all age groups, peptic ulcers were commoner in males than females [44% (85/195) vs 23% (32/139), P < 0.001] and in smokers than non-smokers [47% (46/97) vs 32% (50/159), P < 0.05]. Males, heavy smokers and those with a family history of peptic ulcer had increased adjusted odds of having a peptic ulcer (2.59, 1.96 and 1.90, respectively). Corresponding odds ratios for those aged under 45 were 2.59, 0.94 and 2.52. In H. pylori-positive dyspepsia, being a male who either smoked heavily or had a family history of peptic ulcer gave a sensitivity and positive predictive value of peptic ulcer of 86 and 45% for all age groups and 85 and 49% for those aged under 45. Conclusion Male H. pylori dyspeptics who smoke >10 cigarettes per day and/or have a family history of peptic ulcer are likely to have peptic ulcer and are thus likely to benefit from empirical eradication therapy. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 15 条
[1]   OUTPATIENT ENDOSCOPIC SURVEY OF SMOKING AND PEPTIC-ULCER [J].
AINLEY, CC ;
FORGACS, IC ;
KEELING, PWN ;
THOMPSON, RPH .
GUT, 1986, 27 (06) :648-651
[2]   Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German gastric ulcer study [J].
Bayerdorffer, E ;
Miehlke, S ;
Lehn, N ;
Mannes, GA ;
Hochter, W ;
Weingart, J ;
Klann, H ;
Sommer, A ;
Heldwein, W ;
Hatz, R ;
Simon, T ;
Bolle, KH ;
Bastlein, E ;
Meining, A ;
Ruckdeschel, G ;
Stolte, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (04) :343-349
[3]  
*BRIT SOC GASTR, 1996, GUID DYSP
[4]  
CALAM J, 1993, GASTROENTEROLOGY CLI, P246
[5]  
GEAR MWL, 1989, BRIT J HOSP MED, V41, P438
[6]  
HUNGIN APS, 1994, BRIT J GEN PRACT, V44, P519
[7]  
MARSHALL B, 1983, LANCET, V1, P1273
[8]   The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients [J].
McColl, KEL ;
ElNujumi, A ;
Murray, L ;
ElOmar, E ;
Gillen, D ;
Dickson, A ;
Kelman, A ;
Hilditch, TE .
GUT, 1997, 40 (03) :302-306
[9]   PROSPECTIVE SCREENING OF DYSPEPTIC PATIENTS BY HELICOBACTER-PYLORI SEROLOGY [J].
PATEL, P ;
KHULUSI, S ;
MENDALL, MA ;
LLOYD, R ;
JAZRAWI, R ;
MAXWELL, JD ;
NORTHFIELD, TC .
LANCET, 1995, 346 (8986) :1315-1318
[10]   Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease [J].
Penston, JG .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (04) :469-486